Your session is about to expire
← Back to Search
Other
Virtual Care Coordination for Hepatitis C (STAT-C Trial)
N/A
Waitlist Available
Research Sponsored by Prisma Health-Upstate
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 27 months
Awards & highlights
STAT-C Trial Summary
This trial will test a new way of providing care to people with hepatitis C who live in rural areas with limited access to medical resources. The goal is to see if this new method, which uses a smartphone app to connect patients to care, can help more people overcome the virus.
Eligible Conditions
- Substance Use Disorder
- Hepatitis C
STAT-C Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 27 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~27 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
HCV Treatment Initiation Rates
Secondary outcome measures
HCV Treatment Adherence
HCV Treatment Completion
Rate of Sustained Virologic Response
STAT-C Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Virtual Care CoordinationExperimental Treatment1 Intervention
Participants will download a mobile phone app (emocha) to facilitate care coordination throughout course of HCV treatment
Group II: Treatment as UsualActive Control1 Intervention
TAU group will receive standard care coordination efforts by health care team throughout course of HCV treatment
Find a Location
Who is running the clinical trial?
Prisma Health-UpstateLead Sponsor
82 Previous Clinical Trials
42,792 Total Patients Enrolled
Gilead SciencesIndustry Sponsor
1,082 Previous Clinical Trials
842,607 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You are currently pregnant or breastfeeding.You have had treatment for your condition before and can now be treated with sofosbuvir/velpatasvir.You are willing to be randomly assigned to either the emocha group or the TAU group.
Research Study Groups:
This trial has the following groups:- Group 1: Treatment as Usual
- Group 2: Virtual Care Coordination
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Who else is applying?
What state do they live in?
South Carolina
North Carolina
How old are they?
18 - 65
What site did they apply to?
Prisma Health Upstate
What portion of applicants met pre-screening criteria?
Met criteria
How responsive is this trial?
Most responsive sites:
- Prisma Health Upstate: < 24 hours
Average response time
- < 1 Day
Typically responds via
Phone Call
Share this study with friends
Copy Link
Messenger